USA
Meldepflichtige Eigengeschäfte von Führungskräften (Directors' Dealings) gemäß Art. 19 MAR – wer im eigenen Unternehmen kauft und verkauft.
Datenstand: 23.10.2026 (gestern)
| Gemeldet ↓ | Geschäft | Unternehmen | Insider | Position | Art | Volumen |
|---|---|---|---|---|---|---|
| 06.10.2026 | 06.10.2026 | NEW Germany Fund Inc. | Saba Capital Management, L.P. | 10% Owner | Kauf | 57.553,59 USD |
| 06.10.2026 | 06.10.2026 | Workday, Inc. | David A. Duffield | 10% Owner | Verkauf | 2.002.261,74 USD |
| 06.10.2026 | 06.10.2026 | Workday, Inc. | David A. Duffield | 10% Owner | Verkauf | 3.684.967,99 USD |
| 06.10.2026 | 06.10.2026 | Workday, Inc. | David A. Duffield | 10% Owner | Verkauf | 1.887.802,38 USD |
| 06.10.2026 | 06.10.2026 | Workday, Inc. | David A. Duffield | 10% Owner | Verkauf | 8.583.244,68 USD |
| 06.10.2026 | 06.10.2026 | Workday, Inc. | David A. Duffield | 10% Owner | Verkauf | 1.911.388,35 USD |
| 06.10.2026 | 06.10.2026 | Workday, Inc. | David A. Duffield | 10% Owner | Verkauf | 517.450,08 USD |
| 06.10.2026 | 06.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 43.639,60 USD |
| 06.10.2026 | 06.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 458.681,18 USD |
| 06.10.2026 | 06.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 303.548,48 USD |
| 06.10.2026 | 06.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 65.098,84 USD |
| 06.10.2026 | 06.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 205.790,86 USD |
| 06.10.2026 | 06.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 1.110.553,23 USD |
| 06.10.2026 | 06.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 866.718,37 USD |
| 06.10.2026 | 06.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 586.005,83 USD |
| 06.10.2026 | 06.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 71.497,58 USD |
| 06.10.2026 | 06.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 173.209,23 USD |
| 06.10.2026 | 06.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 393.210,19 USD |
| 06.10.2026 | 06.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 89.228,40 USD |
| 06.10.2026 | 06.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 114.625,94 USD |
| 06.10.2026 | 06.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 170.220,29 USD |
| 06.10.2026 | 06.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 127.231,99 USD |
| 06.10.2026 | 06.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 190.339,09 USD |
| 06.10.2026 | 06.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 147.812,81 USD |
| 06.10.2026 | 06.10.2026 | Artiva Biotherapeutics, Inc. | Fred Aslan | Chief Executive Officer / Director | Verkauf | 168.879,64 USD |
| 06.10.2026 | 06.10.2026 | Verisign Inc. | D. James Bidzos | Exec. Chairman, Pres, & CEO / Director | Verkauf | 117.637,00 USD |
| 06.10.2026 | 06.10.2026 | Verisign Inc. | D. James Bidzos | Exec. Chairman, Pres, & CEO / Director | Verkauf | 322.114,98 USD |
| 06.10.2026 | 06.10.2026 | Verisign Inc. | D. James Bidzos | Exec. Chairman, Pres, & CEO / Director | Verkauf | 524.938,86 USD |
| 06.10.2026 | 06.10.2026 | American Eagle Outfitters Inc. | Cary D. McMillan | Director | Verkauf | 65.829,40 USD |
| 06.10.2026 | 06.10.2026 | Sonic Automotive Inc. | Paul P. Rusnak | 10% Owner | Kauf | 67.028,10 USD |
| 06.10.2026 | 06.10.2026 | Sunrun Inc. | Danny Abajian | Chief Financial Officer | Verkauf | 129.931,14 USD |
| 06.10.2026 | 06.10.2026 | Sunrun Inc. | Maria Barak | Chief Accounting Officer | Verkauf | 13.753,23 USD |
| 06.10.2026 | 06.10.2026 | Sunrun Inc. | Jeanna Steele | Chief Legal & People Officer | Verkauf | 77.967,09 USD |
| 06.10.2026 | 06.10.2026 | Sunrun Inc. | Mary Powell | Chief Executive Officer / Director | Verkauf | 188.939,37 USD |
| 06.10.2026 | 06.10.2026 | Sunrun Inc. | Paul S. Dickson | Pres. & Chief Revenue Officer | Verkauf | 122.971,14 USD |
| 06.10.2026 | 06.10.2026 | Intellinetics, Inc. 🔥 Cluster | Robert Taglich | 10% Owner | Kauf | 20.000,00 USD |
| 06.10.2026 | 06.10.2026 | Recursion Pharmaceuticals, Inc. | Robert Hershberg | Director | Verkauf | 125.000,00 USD |
| 06.10.2026 | 06.10.2026 | Recursion Pharmaceuticals, Inc. | Blake Borgeson | Director | Verkauf | 242.000,00 USD |
| 06.10.2026 | 06.10.2026 | Jazz Pharmaceuticals plc | Renee D. Gala | President & CEO / Director | Verkauf | 472.800,00 USD |
| 06.10.2026 | 06.10.2026 | Alignment Healthcare, Inc. | Hyong Kim | Chief Medical Officer | Verkauf | 269.575,70 USD |
| 06.10.2026 | 06.10.2026 | Neptune Insurance Holdings Inc. | Matthew Paul Duffy | President & Chief Risk Officer | Verkauf | 1.123.966,65 USD |
| 06.10.2026 | 06.10.2026 | Liberty Energy Inc. | Michael Stock | Chief Financial Officer | Verkauf | 66.660,00 USD |
| 06.10.2026 | 06.10.2026 | GAP Inc. | Julie Gruber | Chief Legal&Compliance Officer | Verkauf | 648.679,62 USD |
| 06.10.2026 | 06.10.2026 | Synopsys Inc. | Janet Lee | GC & Corporate Secretary | Verkauf | 281.341,20 USD |
| 06.10.2026 | 06.10.2026 | Synopsys Inc. | Janet Lee | GC & Corporate Secretary | Verkauf | 293.344,16 USD |
| 06.10.2026 | 06.10.2026 | Capital One Financial Corp. | Matthew W. Cooper | General Counsel & Corp Secy | Verkauf | 686.770,00 USD |
| 06.10.2026 | 06.10.2026 | Vistra Corp. | Scott A. Hudson | EVP & President Vistra Retail | Verkauf | 3.558.631,08 USD |
| 06.10.2026 | 06.10.2026 | Verizon Communications Inc. | Kyle Malady | EVP and Group CEO-VZ Business | Verkauf | 50.325,00 USD |
| 06.10.2026 | 07.10.2026 | Pinterest, Inc. | Benjamin Silbermann | Director / 10% Owner | Verkauf | 940.790,62 USD |
| 06.10.2026 | 06.10.2026 | Pinterest, Inc. | Benjamin Silbermann | Director / 10% Owner | Verkauf | 921.600,00 USD |